Acrivon Therapeutics
Biotech company specializing in drug development through early clinical treatment success. Learn more
Launch date
Employees
Market cap
$276m
Enterprise valuation
$100m (Public information from Sep 2024)
Share price
$7.59 ACRV
Cambridge Massachusetts (HQ)
Authorizing premium user...